Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals.
Antiviral Agents
/ therapeutic use
Biopsy
Hepacivirus
/ isolation & purification
Humans
Liver
/ diagnostic imaging
Liver Neoplasms
/ diagnosis
Lymphoma, Large B-Cell, Diffuse
/ diagnosis
Lymphoma, Non-Hodgkin
/ drug therapy
Male
Middle Aged
Positron Emission Tomography Computed Tomography
Sustained Virologic Response
DAAs
HCC
HCV
NHL
Journal
Annals of hepatology
ISSN: 1665-2681
Titre abrégé: Ann Hepatol
Pays: Mexico
ID NLM: 101155885
Informations de publication
Date de publication:
Historique:
received:
14
01
2019
revised:
20
08
2019
accepted:
26
08
2019
pubmed:
7
11
2019
medline:
19
11
2021
entrez:
8
11
2019
Statut:
ppublish
Résumé
The association of Non-Hodgkin lymphomas and Hepatitis C virus is well documented and antiviral treatments facilitate a virological and hematological response in the majority of HCV related Non-Hodgkin lymphomas. The recent years, direct acting antivirals have made cure possible almost for every HCV patient. Some concerns were raised as regards the frequency and the pattern of recurrence in HCV patients with HCC, treated with these agents. We present a patient with DLBCL, in remission after appropriate treatment, HCV cirrhosis that was cured with the new antivirals and shortly after SVR, he experienced a lethal lymphoma recurrence.
Identifiants
pubmed: 31694799
pii: S1665-2681(19)32247-1
doi: 10.1016/j.aohep.2019.08.012
pii:
doi:
Substances chimiques
Antiviral Agents
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
100141Informations de copyright
Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.